Tested Applications
| Positive WB detected in | BXPC-3 cells, HepG2 cells, L02 cells |
| Positive IP detected in | HepG2 cells |
| Positive IHC detected in | human hepatocirrhosis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13725-1-AP targets CBR4 in WB, IHC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4678 Product name: Recombinant human CBR4 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-211 aa of BC033650 Sequence: MDKVCAVFGGSRGIGRAVAQLMARKGYRLAVIARNLEGAKAAAGDLGGDHLAFSCDVAKEHDVQNTFEELEKHLGRVNFLVNAAGINRDGLLVRTKTEDMVSQLHTNLLGSMLTCKAAMRTMIQQQGGSIVNVGSIVGLKGNSGQSVYSASKGGLVGFSRALAKEVARKKIRVNVVAPGFVHTDMTKDLKEEHLKKNIPLGRFGETIEVAH Predict reactive species |
| Full Name | carbonyl reductase 4 |
| Calculated Molecular Weight | 237 aa, 25 kDa |
| Observed Molecular Weight | 28 kDa |
| GenBank Accession Number | BC033650 |
| Gene Symbol | CBR4 |
| Gene ID (NCBI) | 84869 |
| RRID | AB_10643240 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8N4T8 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CBR4 (Carbonyl Reductase 4), also known as SDR45C1, is a mitochondrial matrix protein that participates in mitochondrial fatty acid biosynthesis (mtFAS). It serves as the catalytic subunit of the heterotetrameric 3-ketoacyl-[acyl-carrier-protein] reductase (KAR) complex, which also contains two HSD17B8 polypeptides. CBR4 is downregulated in colorectal cancer and functions as a tumor suppressor by inhibiting cell proliferation, migration, and invasion through the DNMT3B/CBR4/FASN/mTOR axis.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CBR4 antibody 13725-1-AP | Download protocol |
| IP protocol for CBR4 antibody 13725-1-AP | Download protocol |
| WB protocol for CBR4 antibody 13725-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CBR4 Polyclonal antibody (catalog number 13725-1-AP) has 1 total citation. It appears in the journal Frontiers in Immunology (2025), in a study examining the mechanism of IFITM1 regulating epidural scar hyperplasia after laminectomy through the SMAD3/CBR4 pathway. The associated research field is immunology, specifically involving spinal surgery, scar tissue formation, and the SMAD3/CBR4 signaling pathway.
| Species | Application | Title |
|---|---|---|
Front Immunol Mechanism of IFITM1 regulating epidural scar hyperplasia after laminectomy through SMAD3/CBR4 pathway |











